BIVALIRUDIN FOR INJECTION
BIVALIRUDIN FOR INJECTION
Approved
DIN Number
02435268
Drug Class
Human
Market Date
Apr 23, 2019
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02435268
AIG Number0148342001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AE06 BIVALIRUDIN
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification20:12.04.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
BIVALIRUDINActive
Strength: 250 MG / VIAL
Monograph: BIVALIRUDIN